Signed in as:
filler@godaddy.com
Please read this first:
These references were compiled in response to the growing inquiries we have received from the fluoroquinolone affected community. Before proceeding with contact, please review our Disclaimer.
The below mitochondrial listing suggests professionals and entities around the globe, who could evaluate you for possible mitochondria dysfunction. Studies have indicated mitochondrial damage caused by these antibiotics, which can lead to a constellation of systemic health problems.
If you have received care from a doctor who has documented in your medical file fluoroquinolone toxicity linked to your adverse effect(s) and would like to share their contact information for inclusion on our upcoming new list, please use our Contact Us form to help others benefit from their expertise. In the contact box:
- Fill in your name
- Your email address
- And in the 'message' section:
- Please provide the doctor's name
- Institution/clinic name of business
- Specialty, if not primary care
- City and State OR for international > City and Country
Disclaimer:
Treating fluoroquinolone patients requires a personalized approach that takes into account each individual’s unique symptoms, medical history, severity, and metabolic needs. Responses to supplements, treatments, and pharmaceuticals can vary widely.
Our foundation does not endorse any specific medical professional(s), opinions, or treatment protocols, nor do we receive monetary compensation for medical treatments or books.
Beatrice Alexandra Golomb – Physician & Scientist
Dr. Golomb is a leading expert on Fluoroquinolone-Associated Disability (FQAD) and Gulf War illness (GWI). As a Professor of Medicine at UC San Diego and Director of the Golomb Research Group, she has dedicated her career to researching exposures and conditions tied to oxidative stress, mitochondrial dysfunction, and medication-related toxicity. She actively advocates for and guides treatment for those affected by fluoroquinolones. Notable Publication: Fluoroquinolone-Induced Serious, Persistent, Multisymptom Adverse Effects (2015)
Contact: golombresearch@ucsd.edu
Robert Pietruszyński - Physician
Dr. Robert Pietruszyński is a specialist in internal medicine, cardiology, and sports medicine. A 1989 graduate of the Military Medical Academy in Łódź, he works at University Clinical Hospital WAM in Łódź, Poland. He leads vascular diagnostics and CTA research of the heart and aorta, and serves as team doctor for the Polish Cycling Federation, including at multiple Olympic Games. He specializes in echocardiography, stress testing, and CPET, making him a top expert in evaluating physical capacity. Dr. Pietruszyński actively treats FQAD patients, with research on oxidative stress, mitochondrial damage, QT prolongation, and cardiovascular risks. His 2020 Arch Med Sci article analyzed antioxidant therapy for FQAD. He has published works in cardiology, sports medicine, and FQAD.
Contact:
https://www.cms.waw.pl/ Warszawa https://fmclodz.pl/kontakt/ Lodz
Marco Karrer - Physician
As a physician who has personally experienced the side effects of fluoroquinolones, Marco has studied the etiology, pathogenesis, diagnostics, and treatment therapies of Fluoroquinolone Assoicated Disability (FQAD). This unique perspective allows him to guide patients through the challenges this condition presents, incorporating both the knowledge and empathy needed to support those on a path to recovery. Marco resides in Switzerland and has counseled over 150 fluoroquinolone damaged patients in multiple countries via telemedicine consultation.
Contact: https://fqad-support.com/services/
Stefan Pieper - Physician
Dr. Pieper, a former emergency room physician, has treated more than 2,000 patients affected by fluoroquinolones at his integrative medicine clinic in Germany. In response to growing demand, he offers telemedicine consultations for patients outside of Germany. Appointments may be subject to a waiting period. He has written an instrumental book for the medical community: Fluoroquinolone Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria, and has a follow-up book that came out in 2025. The English version will become available later this year.
Contact via email: https://www.praxisdrpieper.de/
Donate with Zelle
On your Zelle account, copy and paste our email address to transfer your donation to our foundation: fq100@protonmail.com
